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ABSTRACT
Objectives: The aim of this study is to assess glycemic control and its relationship with patient characteristics, health-care system factors, and 
self-care management in type II diabetes patients.
Methods: A retrospective cross-sectional study was conducted among 330 type II diabetes patients who met the inclusion criteria and whose medical 
records covered a period of 1 year. Data concerning patient characteristics, health-care system factors, self-care management, and available last 
reading of hemoglobin A1c (HbA1c) were collected through personal interviews and a medical records’ review using structured questionnaires and 
data collection forms. Good glycemic control was defined as HbA1c ≤7%. To assess the results, the Statistical Package for Social Sciences (version 16) 
was used to undertake descriptive, univariate, and multivariate analyses.
Results: The mean±standard deviation age was 60±9.7 years. More than half of the participants were male (51.2%), and the majority had additional 
chronic diseases (88.5%). Of the total 271 participants whose HbA1c levels have been monitored, 16.7% had good glycemic control. Multivariate 
analysis showed that unemployment was significantly related to a decreased odds of good glycemic control (odds ratio=0.34; 95% confidence 
interval=0.12-0.98; p<0.05).
Conclusion: The study noted that the proportion of patients with good glycemic control was low, a result comparable to studies from many countries. 
Further investigation and improvement of inappropriate health-care system factors and self-care management together with educational programs 
that emphasize the importance of self-care management and the health-care providers’ role would be of great benefit in glycemic control.
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INTRODUCTION
The health-care resources limitations and availability in troubled 
countries such as Palestine, in addition to the need for efficient scarce 
resources use, have led to the diabetes prevalence which is high in 
Palestine and expected to increase further in future [1] as demand 
for clinical management, treatment, and comprehensive care rises. 
Diabetes is a costly disease to treat, especially in Palestine where its 
control and prevention resources are limited. Thus, there is a need 
for Palestinian authorities and organizations to track not only the 
disease but also the consequent economic burden placed on their 
society. The high diabetes incidence in Palestine is affecting the most 
productive age groups and is associated with significant morbidity, 
mortality, and economic consequences. To address this, the Palestinian 
ministry of health has, since 1998, developed strategies to enhance the 
management and treatment of diabetes in its centers and hospitals [2].
Persistent hyperglycemia is the main feature of diabetes [3]. Patients 
with diabetes are prone to consequences in both short-term and long-
term diabetic complications. This makes diabetes health-care service 
more complicated and difficult to evaluate than any other diseases 
because the condition needs long-term assessment and evaluation to 
guarantee an appropriate health-care service. Thus, the main aim of 
management and treatment of type II diabetes is to lower fasting blood 
glucose to near normal levels, to prevent or at least delay the occurrence 
of diabetic complications. This can reduce the enormous economic 
costs, but in order to do so, it is very important for those in charge 
of diabetes primary health-care centers to ensure early diagnosis of 
diabetes and take into account patient education and regular follow-up 
through a well-organized surveillance system [4]. To achieve this, they 
need to adopt a conceptual model for examining health-care services 
such as Donabedian’s framework [5].
Three categories of Donabedian’s framework, namely, structure, 
process, and outcomes of care can draw information about health-care 
services. Structure describes how well a program is designed, including 
hospital buildings, scientific disciplines for health-care professionals, 
financing, and equipment. The process of care describes how well a 
program is implemented and the interaction between patients and 
health-care providers throughout the health-care delivery. Outcomes 
describe how well the program is evaluated and it refers to the health-
care effects [5]. These criteria are closely interrelated and must be 
taken into account as a single unit, together with components that 
are interconnected and related to each other. Diabetes control relies 
heavily on patient self-care management that influences almost all 
facets of their day-to-day activities. This study, therefore, assesses 
glycemic control and its relationship to patient characteristics, health-




This study was retrospective cross-sectional. Data collection consisted 
of personal interview and medical records’ review for the past 1 year. 
Glycemic control was determined as an outcome (good versus poor 
glycemic control) while using sociodemographic, clinical characteristics, 
health-care system factors, and self-care management as independent 
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variables. The study instruments have been previously used by other 
studies [6-16].
Study setting
Ramallah is administrative and political capital of the Palestinian 
government and is more developed than other Palestinian cities in 
economic, health, and urban terms. The study was carried out at the 
National Center for Chronic Diseases and Dermatology in Ramallah, 
the first Palestinian governmental tertiary health-care center that has a 
section specializing in providing diabetes care for diabetic patients with 
governmental health insurance in that city. During the study period, the 
researcher visited the center daily to recruit potential participants, 
interview them personally, and review their medical records.
Participants
This study was undertaken with a sample of outpatients recruited 
using a convenient sampling method from a medical records’ list of 
type II diabetes patients, who visited the study setting regularly and 
continuously during the past 1 year. Every patient who met the inclusion 
criteria was asked if he/she would be willing for study participation. The 
information sheet was used to inform patients about the study aim, and 
the researcher asked them to read it carefully and sign a consent form 
to participate in it. Subsequently, the inclusion criteria for this study 
were: Patients diagnosed with type II diabetes for 1 year or more, with 
available medical file, currently being under medical care for type II 
diabetes with at least two outpatient visits during the past 1 year, and 
those willing for study participation. The main exclusion criteria were 
those suffering from Type I diabetes or gestational diabetes and those 
with physical and mental conditions that could interfere with their 
ability to understand and/or complete data collection requirements.
Sample size
There are no previous publications about glycemic control among 
Palestinian diabetic patients and the assumption of the maximum rate 
of good glycemic control in Palestine to be 50%. The study required an 
adequate sample size from a target population of 1200 type II diabetes 
patients. The outcome is dichotomous (good vs. poor glycemic control), 
and the level of confidence was presented with a 95% confidence 
interval (CI) with the significance level set at 5% (two-tailed) [17]. 
Calculations estimated that a sample of 292 type II diabetes patients 
was needed upon using the Daniel formula. However, since the total 
target population is <10,000, an adjusted sample size of 235 patients 
was decided [17-19]. To minimize erroneous results and increase the 
study reliability, the researcher recruited a minimum sample size of 
247 type II diabetes patients [20,21].
Ethical approval
This study was approved by the Palestinian Ministry of Health and 
Research Management Institute at Universiti Teknologi MARA. The 
researcher provided each participant with an information sheet copy 
which included a brief explanation about the study and its purposes, 
along with the consent form which identifies the requirements and 
condition of study accession, and participant’s rights. The researcher 
also gave an individual oral explanation to participant about the study 
importance and their rights before asking them to sign the consent 
form once they agreed to join the study.
Recruitment procedure
The potential participants who met the sampling criteria were screened 
from the medical records. Each patient in the center’s waiting area who 
met the sampling criteria was asked if he/she was willing to participate 
in the study. If the patient agreed to talk for possible participation, 
then a consent form was read to the patient and an approval signature 
obtained. Following this, the study instruments were presented and 
explained during the interview, and all participants completed the 
questionnaires and forms in a center’s private area. These were later 
compared with their medical records. The forms and questionnaires 
for data collection were: Sociodemographic and health questionnaire, 
Patient Perception of Diabetes Care Quality Questionnaire (PPDCQ), 
diabetes professional performance checklist, diabetes self-care 
management scale, and medical records’ checklist.
Instruments
Sociodemographic and health questionnaire
This questionnaire section was designed to collect data about patient 
characteristics. It included sociodemographic data information 
concerning age, gender, marital status, household monthly income, 
educational level, place of residence, occupation, working days and 
hours, and health insurance. The other part covered patient clinical 
characteristics data including medical history, type II diabetes duration, 
body mass index, smoking status, and any medications. The medical 
history question was presented to the participant as a list of illnesses 
with a dichotomous (yes/no) response [6,7]. All participants were 
asked to state their current antidiabetic treatment to investigate the 
antidiabetic therapy type as well as insulin treatment during the past 
1 year. Data concerning the number of medications taken on a daily 
basis were collected from the medical records.
Patient Perception of Diabetes Care Quality Questionnaire
The attending physician’s specialty, details of preventive education, 
and feedback on patient perception of patient-professional interaction 
together with satisfaction with this interaction were obtained and 
measured and using a PPDCQ [8,9]. The physician’s specialty was 
categorized as diabetologist or non-diabetologist. If a participant 
could not identify the specialty, the researcher asked the physicians 
personally. Because there is no specific Palestinian system for 
diabetes care institute accreditation, criteria developed by Taiwanese 
Association of Diabetes Educators were used in the study after it was 
found best suited for assessment [22,23].
The preventive education evaluation consists of five dimensions, namely, 
diet education, exercise education, foot care instructions, self-blood 
glucose monitoring, and smoking status. The score for each dimension 
is 10. Therefore, the diabetes preventive education maximum total score 
is 50. The cumulative preventive education percentage is the mean total 
score as opposed to the maximum total score. Preventive education was 
considered inappropriate when the mean total score was lower than 
the average score (the cumulative percentage is <50%) and appropriate 
if greater or equal the average score (cumulative percentage ≥50%).
Patient satisfaction with professional scale is the foundation part of 
the PPDCQ that includes five dimensions referring to physician and 
four each for nurse and dietician, respectively. Two additional items 
asked patients if they received education and care from a nurse and/or 
dietician. Subsequently, the subscales of nurse and dietician were given 
0 if the participant did not get any such care and education. Potential 
rating categories range from never (one) to always (five). Thus, scores 
for subscales ranged from physician (6-30), nurse (0-25), to dietician 
(0-25). Consequently, the total patient satisfaction with professional 
scale score ranged from 6 to 80. The higher the score means, the higher 
the patient satisfaction with health-care professionals. The mean 
total patient satisfaction with professional scale score was calculated 
as opposed to the maximum total score to calculate the cumulative 
percentage. Appropriate patient-professional relationship refers to a 
mean total patient satisfaction with professional scale score greater 
or equal to the average score (cumulative percentage ≥50%) and 
inappropriate when the total score is lower than the average score 
(cumulative percentage <50%).
Diabetes professional performance checklist
The quality of follow-up is a health-care system factor represented as a 
measurement of diabetic complications’ risk factors. Data about quality 
of follow-up were collected from a medical records’ review and personal 
interviews using the diabetes professional performance checklist and 
the PPDCQ which included blood test evaluation for hemoglobin A1c 
(HbA1c), fasting blood glucose, lipid profile (cholesterol, triglycerides, 
high-density lipoprotein, and low-density lipoprotein), blood pressure 
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checkup frequency, nephropathy assessment (serum creatinine, 
urine analysis, and microalbumin), feet and fungus examination, and 
ophthalmoscope examination [10]. The maximum score for each 
dimension is 10, a total of 70; the maximum quality of follow-up total 
score. Table 1 shows the quality of follow-up measure. The cumulative 
percentage is the mean quality of follow-up total score as opposed to 
the maximum total score. The quality of follow-up was considered 
inappropriate when the mean total score was lower than the average 
score (cumulative percentage <50%) and appropriate when greater or 
equal the average score (cumulative percentage ≥50%).
Self-care management scale
Diabetes self-care management were measured using a questionnaire 
consisting of four dimensions related to diet, physical exercise, and self-
blood glucose monitoring identified the degree of following a diabetic 
meal plan, a frequency of 30 minutes of daily physical exercise and the 
number of glucose testing per week [11,24], and the eight-item Morisky 
Medication Adherence Scale (MMAS-8) that consists of 8 items related 
to medication adherence [25]. The first seven items were yes/no 
questions while the eighth item was answered on a 5-point Likert scale. 
Scores can range from zero to eight, with one score given for each “No” 
answer except for item number five where one score was given for a 
“Yes” answer, and the eighth item with zero given for “all the time” and 
one score for “never/rarely” [6,7,12,13,26].
In the category of self-care management, follow a diabetic meal plan 
for 3 days or more in the previous 7 days, meant that the participants 
followed a diabetic meal plan as recommend by the dietician. In 
addition, participants who reported that they walked 3 days or more 
in the previous 7 days were considered as being engaged in at least 
30 minutes in daily physical exercise. Self-blood glucose monitoring 
was defined as those who stated that they performed home glucose 
monitoring for 5 days or more in the previous 7 days [27,28]. Total 
medication adherence score ranged from zero to eight. Participants 
were classified as non-adherent if their total score was less than six and 
adherent for those whose total scores was six or more.
Medical records’ checklist
The medical records’ checklist was the basic instrument used by the 
researcher to collect data concerning prescribed medications, therapy-
related factors, and quality indicators of diabetes control from medical 
records’ review [14,16]. A review of these using the checklist was an 
effective technique in examining the accuracy of participant follow-up 
by checking the number of recorded visits number. Therapy-related 
factors consist of the medication profile of type II diabetes patients. 
Therefore, prescribed medications for type II diabetes, antihypertensive 
medications, statins, and aspirin were included in the prescribed 
medications list studied. In addition, the antidiabetic treatment regimen 
was the main variable used for assessing drug treatment.
Table 2 shows the quality indicators of diabetes control. They were 
inclusive of HbA1c, fasting blood glucose, cholesterol, triglycerides, high-
density lipoprotein, low-density lipoprotein, and blood pressure. The 
glycemic control status was categorized as good if HbA1c values were 
≤7% and poor if HbA1c values were >7% [29]. Hypertriglyceridemia 
refers to a triglyceride level ≥150 mg/dl. High-density lipoprotein is 
considered low when the level is <35 mg/dl and excellent when the 
level is higher than 35 mg/dl. Low-density lipoprotein is considered 
high when the level is ≥100 mg/dl [30]. Furthermore, patients receiving 
medications for any of the above conditions were considered as having 
the condition [27].
Statistical analysis
The Statistical Package for the Social Sciences (version 16) was used to 
carry out statistical analysis. Data were described as mean±standard 
deviation (SD) and median (interquartile range: Q1-Q3) for continuous 
variables and proportions for categorical variables. Binary logistic 
regression was used to assess statistical significance of the difference 
in the good glycemic control according to independent variables. 
Multiple logistic regression was carried out using variables that showed 
significance in binary logistic regression to identify factors related to 
good glycemic control. p<0.05 was considered statistically significant.
RESULT
Participants’ characteristics
A total of 330 patients were recruited. The mean±SD age of the 
participants was 60±9.7 (range=28-85) years. More than half of the 
participants were male (169, 51.2%). 253 participants (76.7%) were 
married. The majority were low-income participants (228; 69.1%) 
and held school certificates (220; 66.7%). Approximately half of the 
participants were city residents (168; 50.9%), and a higher proportion 
was housewives (130; 39.4%). The mean±SD daily working hours 
Table 1: Description of quality of follow-up






































Microalbumin (with or without above)





Feet and fungus examination Yes/No Medical records+PPDCQ - 10
Ophthalmoscope examination 1 time/year Medical records+PPDCQ 10 10
Total score 70 70
HbA1c: Hemoglobin A1c, PPDCQ: Patient Perception of Diabetes Care Quality Questionnaire
344
Asian J Pharm Clin Res, Vol 10, Issue 9, 2017, 341-347
 Mosleh et al. 
and weekly working days were 7.4±2.5 and 5.5±0.9, respectively. The 
overwhelming majority of participants were covered by governmental 
health insurance only (306; 92.7%).
Participants reported an average of 1.9±1.7 additional diabetic 
complications (median=2; Q1-Q3: 0-3) and 1.8±1.8 additional 
non-diabetic comorbidities (median=2; Q1-Q3: 1-2), respectively. 
Tuberculosis (265; 80.3%) and hypertension (208; 63.0%) were 
the most frequently reported additional chronic diseases among the 
participants. 38 participants (11.5%) reported that they did not suffer 
from additional chronic diseases while approximately half of the 
participants reported four or more additional chronic diseases (166; 
50.3%). Obesity (body mass index ≥30 kg/m2) was the most frequently 
reported (152; 46.1%), and more than half of the participants reported 
that they were non-smokers (209; 63.3%) while 207 (62.7%) had been 
diagnosed with type II diabetes for more than 10 years. Participants 
reported an average of 6.4±2.8 (median=6; Q1-Q3: 5-8) different 
medications taken on daily basis.
Reported health-care system factors
The majority of the participants reported that the physicians were 
diabetologists (327; 99.0%). More than half of the participants 
reported taking a combination treatment of oral hypoglycemic drugs 
and insulin (181; 54.8%). 74 participants (22.4%) were on insulin only 
and 74 (22.4%) others received only oral hypoglycemic drugs. Aspirin 
and statins were prescribed for 188 participants (57%) and 203 
participants (61.5%), respectively. In addition, angiotensin-converting 
enzyme inhibitors were taken by more than half the participants (186; 
56.4%) compared to the other prescribed therapies for hypertension 
taken by the other 53.6%.
The mean±SD quality of follow-up total score was 38.8±13.2 
(median=40; Q1-Q3: 32.5-47.5), which was higher than the average 
score (cumulative percentage=55.4%). The highest quality of follow 
score was for blood pressure measurement (mean±SD=8.8±3), and 
HbA1c was found to have the lowest score (mean±SD = 3.8±2.7). 
The mean±SD preventive education total score was higher than the 
average score (33.1±16.1; cumulative percentage=66.2%), and the 
median was 40 (Q1-Q3: 20-50). The mean±SD patient satisfaction with 
professional scale total score was 38.5±15.9, which was lower than the 
average score (cumulative percentage=48.1%), and the median was 30 
(Q1-Q3: 28-52). 81 participants (24.6%) reported that they received 
diabetes education from nurses, and 91 (27.6%) received diabetes 
education from dieticians. The mean±SD physician total score was 
27.2±4 (median=29; Q1-Q3: 26-30). The mean±SD nurse and dietician 
total scores were 22.3±2.6 (median=23; Q1-Q3: 20.5-24) and 21±5.1 
(median=24; Q1-Q3: 20-25), respectively.
Reported self-care management
More than half of the participants followed a diabetic meal plan (182; 
55.2%). 179 participants (54.2%) participated in physical exercise, and 
more than one-quarter tested their blood glucose level at home (86; 
26.1%). 250 participants answered the questions regarding medication 
adherence. The mean±SD MMAS-8 total score was 6.3±1.6, which was 
higher than the average score (cumulative percentage=78.8%), and the 
median was 7 (Q1-Q3: 5.5-8). The majority were adherent (180; 72%) 
while more than quarter (70; 28%) were non-adherent.
Description of quality indicators of diabetes control
HbA1c was not measured for 59 participants (17.9%). The mean±SD 
HbA1c level was 8.4±1.7 (median=8.1; Q1-Q3: 7.3-9.2). Only 20.3% of 
the participants who have been pursuing their HbA1c levels achieved 
good glycemic control, and the glycemic control for 79.7% of them was 
poor, indicating a need for intensive treatment. Fasting blood glucose 
was not measured for 47 participants (14.7%). The mean±SD fasting 
blood glucose level was 182±77.4 (median=165; Q1-Q3: 129-212). 
Based on the World Health Organization medical standards of diabetes 
care, less than a quarter of the participants (23.3%) whose fasting 
blood glucose levels have been monitored were under acceptable 
control (90-130 mg/dl). The fasting blood glucose level for the rest of 
them (169; 59.7%) was poor (>150 mg/dl).
Cholesterol level was examined for 261 participants, and only 
15 (5.7%) were within the acceptable control (200-220 mg/dl). 
Interestingly, none of the participants revealed a poor cholesterol 
level control (>220 mg/dl), and the cholesterol level control of the 
246 participants (94.3%) was good (<200 mg/dl). The triglyceride 
level was not measured for 95 participants (28.8%). 93 participants 
(39.6%) were within the acceptable triglyceride control (<150 mg/
dl). However, the results were not encouraging, considering that 
almost 61% of those had high triglyceride level (≥150 mg/dl). Both 
high-density lipoprotein and low-density lipoprotein were examined 
for a very low proportion of the participants (35, 10.6%; 27, 8.2%, 
respectively). The blood pressure of 16 participants (4.8%) was not 
examined. Poor blood pressure control (>140/90) was not noticed 
among the participants.
Factors relating to good glycemic control
The univariate analysis (Table 3) did show a significant relationship 
between good glycemic control and marital status, occupation, diabetes 
duration, and a number of medications and prescribed therapies 
in terms of insulin-taking and an antidiabetic treatment regimen. 
Married participants and those who were unemployed were less 
likely to have good glycemic control ([odds ratio (OR)=0.5; 95% CI of 
0.2-0.9] and [OR=0.3; 95% CI of 0.1-0.7] respectively). Participants 
with long diabetes duration and a high number of medications 
were less likely to have good glycemic control ([OR=0.95; 95% CI of 
0.91-1.00] and [OR=0.9; 95% CI of 0.8-1.0] respectively). Participants 
who were not on insulin were more likely to be under good glycemic 
control ([OR=2.5; 95% CI of 1.3-4.7]). Participants whose antidiabetic 
treatment regimen was a combination treatment of oral hypoglycemic 
drugs and insulin were less likely to be under good glycemic control 
([OR=0.5; 95% CI of 0.3-0.8]). The multivariate analysis (Table 4) 
showed that unemployment was significantly related to decreased odds 
of being under good glycemic control. Compared to those employed, 
unemployed participants were less likely to achieve good glycemic 
control ([OR=0.34; 95% CI of 0.12-0.98]).
DISCUSSION
The proportion of participants with HbA1c levels ≤7% in this study 
was lower than that of the studies done in France and Spain [31,32]. 
In terms of comparison of the study results with that of the Al-Rowais’ 
study of type II diabetes patients conducted in the Kingdom of Saudi 
Arabia [33], the percentage of participants who obtained acceptable 
HbA1c levels (6-8%) was almost the same. About 66.7% of the study 
population in Kuwait had poor glycemic control (HbA1c >7%) [34]. Less 
than half of patients in Pakistan had HbA1c level >7.5% (46.7%) [35]. 
Glycemic control in Palestine indicates a need for more research and 
Table 2: Quality indicators of diabetes control
Item Category




90-130 mg/dl - achieved control, >150 mg - did not 
achieve control
Cholesterol <200 mg/dl - good control, 
200-220 mg/dl - acceptable, >220 mg/dl - poor control
Triglycerides <150 mg/dl - good control, ≥150 mg/dl - poor control
High-density 
lipoprotein
>35 mg/dl - good control, <35 mg/dl - poor control
Low-density 
lipoprotein
<100 mg/dl - optimal control, 
100-130 mg/dl - acceptable control, 
>130 mg/dl - poor control
Blood 
pressure
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improvement. The fasting blood glucose level for more than half of the 
participants indicates a need for intensive treatment and a diet regimen. 
This sheds light to review diabetes care infrastructure and policies to 
develop awareness of issues concerning diabetes health-care service.
Blood lipid examination was done with each component separately. 
Hypercholesterolemia and hypertriglyceridemia were major treatable 
cardiovascular disease risk factors among the participants [36]. Hence, 
the results proved that steps must be taken to improve their lipid 
profile control. This is another medical health outcome and part of 
the diabetes health-care system. The blood pressure can be addressed 
if both patients and health-care professionals can be made aware of 
the seriousness of hypertension and the need to provide a test for this 
as part of diabetes care [37]. In addition, the availability of standard 
clinical guidelines for blood pressure management, training programs 
for healthcare professionals which result in the ease of using blood 
pressure screening device, as well as easy and efficient access to 
blood pressure management services is desirable [38]. Blood pressure 







Odds ratio with 95% CI p value
Age category
28-37 6 (2.2) 3 (5.5) 3 (1.4) Reference (1) 0.339
38-47 31 (11.4) 7 (12.7) 24 (11.1) 0.3 (0.05-1.8)
48-57 91 (33.6) 14 (25.5) 77 (35.6) 0.2 (0.0-1.0)
58-67 96 (35.4) 20 (36.4) 76 (35.2) 0.3 (0.1-1.4)
≥68 47 (17.3) 11 (20.0) 36 (16.7) 0.3 (0.1-1.7)
Gender
Male 138 (50.9) 23 (41.8) 115 (53.2) Reference (1) 0.132
Female 133 (49.1) 32 (58.2) 101 (46.8) 1.6 (0.9-2.9)
Marital status
Single 65 (24.0) 20 (36.4) 45 (20.8) Reference (1) 0.018
Married 206 (76.0) 35 (63.6) 171 (79.2) 0.5 (0.2-0.9)
Income level (JDs)
<500 187 (69.0) 32 (58.2) 155 (71.8) Reference (1) 0.054
≥500 84 (31.0) 23 (41.8) 61 (28.2) 1.8 (1.0-3.4)
Educational level
Illiterate 28 (10.3) 7 (12.7) 21 (9.7) Reference (1) 0.183
≤High school 181 (66.8) 31 (56.4) 150 (69.4) 0.6 (0.2-1.6)
>High school 62 (22.9) 17 (30.9) 45 (20.8) 1.1 (0.4-3.1)
Occupation
Employed 103 (38.0) 26 (47.3) 77 (35.6) Reference (1) 0.036
Unemployed 61 (22.5) 5 (9.1) 56 (25.9) 0.3 (0.1-0.7)
Housewife 107 (39.5) 24 (43.6) 83 (38.4) 0.9 (0.5-1.6)
Place of residence
City 140 (51.7) 32 (58.2) 108 (50.0) Reference (1) 0.279
Village and refugee camp 131 (48.3) 23 (41.8) 108 (50.0) 0.7 (0.4-1.3)
Number of chronic diseases 4.0 (2.0-6.0) 3.0 (1.0-5.0) 4.0 (2.0-6.0) 0.9 (0.8-1.0) 0.116
Body mass index
Normal 45 (16.6) 12 (21.8) 33 (15.3) Reference (1) 0.500
Overweight 98 (36.2) 18 (32.7) 80 (37.0) 0.6 (0.3-1.4)
Obese 128 (47.2) 25 (45.5) 103 (47.7) 0.7 (0.3-1.5)
Diabetes duration 14.0 (9.0-20.0) 12.0 (6.0-16.0) 15.0 (10.0-20.0) 0.95 (0.91-1.00) 0.035
Smoking status
Smoker 98 (36.2) 22 (40.0) 76 (35.2) 1.2 (0.7-2.3) 0.507
Non-smoker 173 (63.8) 33 (60.0) 140 (64.8) Reference (2)
Number of medications 7.0 (5.0-8.0) 6.0 (4.0-7.0) 7.0 (5.0-9.0) 0.9 (0.8-1.0) 0.008
Insulin treatment
Yes 207 (76.4) 34 (61.8) 173 (80.1) Reference (1) 0.005
No 64 (23.6) 21 (38.2) 43 (19.9) 2.5 (1.3-4.7)
Antidiabetic therapy
Monotherapy 112 (41.3) 31 (56.4) 81 (37.5) Reference (1) 0.012
Combination 159 (58.7) 24 (43.6) 135 (62.5) 0.5 (0.3-0.8)
Followed a diabetic meal plan
Yes 157 (57.9) 32 (58.2) 125 (57.9) 1.0 (0.6-1.8) 0.967
No 114 (42.1) 23 (41.8) 91 (42.1) Reference (1)
Physical exercise participation
Yes 140 (51.7) 31 (56.4) 109 (50.5) 1.3 (0.7-2.3) 0.435
No 131 (48.3) 24 (43.6) 107 (49.5) Reference (1)
Self-blood glucose monitoring
Yes 69 (25.5) 16 (29.1) 53 (24.5) 1.3 (0.7-2.4) 0.489
No 202 (74.5) 39 (70.9) 163 (75.5) Reference (1)
Medication adherence
Adherent 147 (73.1) 35 (77.8) 112 (71.8) 1.4 (0.6-3.0) 0.426
Non-adherent 54 (26.9) 10 (22.2) 44 (28.2) Reference (1)
Quality of follow-up score 42.5 (35.0-50.0) 42.5 (35.0-45.0) 42.5 (35.0-50.0) 0.98 (0.96-1.01) 0.188
Preventive education score 40.0 (30.0-50.0) 40.0 (20.0-40.0) 40.0 (30.0-50.0) 0.99 (0.97-1.01) 0.217
PSPS score 30.0 (28.0-52.0) 30.0 (28.0-52.0) 30.0 (28.0-52.8) 1.01 (0.99-1.03) 0.341
n: Valid number, CI: Confidence interval, JDs: Jordanian dinars, PSPS: Patient satisfaction with professional scale
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examination is the first measurement that should be done.
The finding of the univariate analysis of factors relating to good glycemic 
control is inconsistent with what is reported by other studies [39,40], 
but consistent with others [39,41] which noted that a progressive 
impairment of insulin secretion results from pancreatic β-cell failure, 
worsening type II diabetes over time, may lead to a negative impact 
on patient response to diet alone and/or oral hypoglycemic drugs and 
the need for a combination treatment of oral hypoglycemic drugs and 
insulin, higher doses, and/or additional medication which increases 
over time. However, an interrupted insulin supply in some cases and 
high insulin prices outside the governmental centers and the discomfort 
of insulin usage compared to oral hypoglycemic drugs could be a causal 
factor in poor glycemic control due to the insulin supply delay for more 
progressive type II diabetes patients.
The result of multivariate analysis as with previous studies is attributed 
to lower income and lack of family support, depression and poor 
mental health due to the living difficulties, and the lack of minimum 
basic needs. These or a combination of them have resulted in patient 
reluctance to visit the clinic regularly, possibly due in part to feeling 
uncomfortable when asked questions [42-46]. The lack of a significant 
relationship between self-care management and glycemic control in the 
study is inconsistent with almost all of the previous studies [27,47-49]. 
This finding reflects a limited participant’s credibility in answering 
self-care management items. Continuous education is recommended 
for motivating patients to overcome this and encourage them to tell the 
truth. This study was the first conducted in Palestine to examine the 
diabetes health-care services through identifying possible significant 
predictors for good glycemic control using binary and multiple logistic 
regression procedures. However, this study is cross-sectional and 
cannot establish causal and sequential relationships. This study may 
also be limited by sample and recall bias because its findings concerning 
self-care management were not congruent with the multiple studies’ 
findings.
CONCLUSION
The quality of follow-up and preventive education was appropriate, but 
apparently, patient-professional relationship was inappropriate. These 
findings need further investigation because of the marked disparity 
of times, at which HbA1c levels were tested among the participants. 
However, the study is a preliminary indication that diabetes health-
care service in Palestine has a great deal of room for research 
and improvement. A clear health policy is needed in the diabetes 
management, and it is vital for health-care professionals to focus on 
unemployed patients with a long diabetes duration, inappropriate 
health-care system factors, and prescription patterns compatible with 
a non-interrupted insulin supply which constitutes the most prominent 
Table 4: Multivariate analysis of factors related to good glycemic control
Variable Coefficient (β) SE Wald Odds ratio with 95% CI p value
Marital status
Single Reference (1) 0.065
Married −0.69 0.37 3.41 0.50 (0.24-1.04)
Occupation
Employed Reference (1)
Unemployed −1.08 0.54 4.03 0.34 (0.12-0.98) 0.045
Housewife −0.28 0.38 0.56 0.76 (0.36-1.58) 0.455
Diabetes duration −0.02 0.03 0.34 0.98 (0.93-1.04) 0.560
Number of medications −0.11 0.06 3.28 0.89 (0.79-1.01) 0.070
Insulin treatment
Yes Reference (1) 0.726
No 0.18 0.51 0.12 1.20 (0.44-3.27)
Antidiabetic therapy
Monotherapy Reference (1) 0.379
Combination −0.38 0.44 0.77 0.68 (0.29-1.60)
SE: Standard error, CI: Confidence interval
challenge to health-care providers and patients alike. An important 
initiative that needs to be adopted is the provision of a base for 
continuous prescription audit in the primary care setting.
The lack of a significant relationship between health-care system 
factors, self-care management, and good glycemic control is significant 
indicators of the need for an educational program that emphasizes 
lifestyle modification and the self-care management importance. 
The health-care provider’s role is also an essential factor in glycemic 
control. Longitudinal research with multivariate causal models is 
recommended, as are other factors such as diabetes-related knowledge, 
belief in medication, and social support, for further investigation.
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